You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chloramphenicol succinate

Showing 1 - 25 of 190
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Osteomyelitis Trial in Louisville (oral antibiotics, intravenous antibiotics)

Terminated
  • Osteomyelitis
  • oral antibiotics
  • intravenous antibiotics
  • Louisville, Kentucky
    University of Louisville
Apr 2, 2021

Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match

Not yet recruiting
  • Obstructive Hypertrophic Cardiomyopathy (oHCM)
  • Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
  • +3 more
  • (no location specified)
Mar 2, 2023

Overactive Bladder Trial in Shanghai (electroacupuncture, Solifenacin Succinate Tablets)

Not yet recruiting
  • Overactive Bladder
  • electroacupuncture
  • Solifenacin Succinate Tablets
  • Shanghai, Shanghai, China
    Longhua Hospital Shanghai University of Traditional Chinese Medi
Mar 23, 2023

Gastric Cancer Trial in Seoul (Arm I : Experimental (Prucalopride succinate group), Arm II : Control (Mosapride citrate group))

Completed
  • Gastric Cancer
  • Arm I : Experimental (Prucalopride succinate group)
  • Arm II : Control (Mosapride citrate group)
  • Seoul, Korea, Republic of
    GangnamSeverance Hospital
Jul 21, 2023

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)

Not yet recruiting
  • End-Stage Kidney Disease
  • End-Stage Renal Disease
  • Boston, Massachusetts
  • +4 more
Jun 26, 2023

Overactive Bladder, Benign Prostate Hyperplasia, Transurethral Resection of Prostate Trial in Soul (Solifenacin Succinate,

Completed
  • Overactive Bladder
  • +3 more
  • Solifenacin Succinate
  • Placebo
  • Soul, Korea, Republic of
    (unnamed)
Jul 26, 2022

Assay to Measure Beta Blocker Adherence

Recruiting
  • Congestive Heart Failure
  • Medication Adherence
  • Quest beta blocker assay
  • Akron, Ohio
    Summa Health System
Mar 4, 2022

Overactive Bladder in Parkinson's Disease Trial in Miami, Tampa, Atlanta (solifenacin succinate (VESIcare), )

Completed
Has Results
  • Overactive Bladder in Parkinson's Disease
  • solifenacin succinate (VESIcare)
  • placebo
  • Miami, Florida
  • +2 more
Nov 8, 2021

Nausea and Vomiting of Pregnancy Trial in United States (doxylamine succinate 10 mg/pyridoxine HCl 10 mg, Placebo)

Completed
Has Results
  • Nausea and Vomiting of Pregnancy
  • doxylamine succinate 10 mg/pyridoxine hydrochloride 10 mg
  • Placebo
  • Washington, District of Columbia
  • +6 more
Nov 22, 2021

Hypertension Trial in Aurora (drug, genetic, procedure)

Terminated
Has Results
  • Hypertension
  • metoprolol succinate
  • +2 more
  • Aurora, Colorado
    University of Colorado Denver; Emergency Department
Aug 18, 2021

Cardiac Disease, Bleeding Postoperative Trial in Aurora (Fresh Autologous whole Blood, Standard of Care Expectant management of

Recruiting
  • Cardiac Disease
  • Bleeding Postoperative
  • Fresh Autologous whole Blood
  • Standard of Care Expectant management of bleeding
  • Aurora, Colorado
    University of Colorado Hospital
Jan 28, 2022

Correction of Metabolic Disorders and Its Effect on Respiratory

Completed
  • COVID-19
  • Nizhny Novgorod, Russian Federation
    Nizhegorodskaya Regional Clinical Hospital named after N.A. Sema
Dec 23, 2021

National CounterACT Initiative

Active, not recruiting
  • Mitochondrial Alteration
    • Philadelphia, Pennsylvania
      Children's Hospital of Philadelphia
    Feb 24, 2022

    Metastatic Melanoma, Skin Cancer, Tumor Trial in New York (ADI PEG 20)

    Completed
    Has Results
    • Metastatic Melanoma
    • +2 more
    • ADI PEG 20
    • New York, New York
    • +1 more
    Oct 3, 2022

    MDD Trial in Beijing (Desvenlafaxine Succinate Sustained-Release Tablet , Duloxetine Hydrochloride Enteric-coated Capsule

    Completed
    • Major Depressive Disorder
    • Desvenlafaxine Succinate Sustained-Release Tablet , Duloxetine Hydrochloride Enteric-coated Capsule Placebo
    • +3 more
    • Beijing, China
      Beijing Anding Hospital
    Dec 1, 2021

    Healthy Trial in Madison (Radiolabeled Prucalopride Succinate)

    Completed
    Has Results
    • Healthy
    • Radiolabeled Prucalopride Succinate
    • Madison, Wisconsin
      Covance Global Clinical Research Unit Inc.
    May 26, 2021

    Efficiency of Drug Reamberin® in Intensive Care of Acute Ethanol

    Recruiting
    • Ethanol Intoxication
    • Moscow, Russian Federation
    • +8 more
    Jan 27, 2023

    Metabolic Acidosis Trial in Russian Federation (Meglumine Sodium Succinate, Placebo)

    Recruiting
    • Metabolic Acidosis
    • Meglumine Sodium Succinate
    • Placebo
    • Arkhangel'sk, Russian Federation
    • +5 more
    Dec 6, 2021

    Migraine in Adults Trial in Beijing (sumatriptan 85mg and naproxen sodium 500mg, Placebo)

    Recruiting
    • Migraine in Adults
    • sumatriptan 85mg and naproxen sodium 500mg
    • Placebo
    • Beijing, China
      Peking University Third Hospital
    Jul 4, 2021

    Keratoconus Trial in Napoli (accelerated custom-fast CXL, Standard CXL)

    Completed
    • Keratoconus
    • accelerated custom-fast CXL
    • Standard CXL
    • Napoli, Italy
      Pellegrini Hospital
    Aug 24, 2021

    Chronic Heart Failure Trial in Odense (Carvedilol, Metoprolol Succinate)

    Not yet recruiting
    • Chronic Heart Failure
    • Odense, Region Of Southern Denmark, Denmark
      Department of Cardiology, Odense University Hospital
    Aug 8, 2021

    Obesity, Insulin Sensitivity/Resistance, Diabetes Type 2 Trial in Tarragona (dietary intervention)

    Recruiting
    • Obesity
    • +2 more
    • dietary intervention
    • Tarragona, Spain
      Hospital Universitari Joan XXIII de Tarragona. IISPV
    Sep 2, 2021

    Pulmonary Disease, Chronic Obstructive Trial in London (GSK961081, GSK961081 matching )

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • London, United Kingdom
      GSK Investigational Site
    Sep 28, 2021

    Depressive Disorder, MDD Trial in United States (Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR))

    Completed
    Has Results
    • Depressive Disorder, Major Depressive Disorder
    • Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)
    • Little Rock, Arkansas
    • +8 more
    Aug 17, 2021